SummaryDr Mario Raviglione, consultant to a TB project with NIH and an HPV project at WHO's IARC, highlighted the need for improved laboratory capacity to identify emerging pathogens, stronger genomic surveillance, adequate facilities and trained personnel, and the ability to rapidly produce vaccines when needed.